Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elastic NV (ESTC) vs Gilead Sciences, Inc. (GILD) Price & Performance

Elastic NVTrade
Gilead Sciences, Inc.Trade

Price performance (Past 24H)

Key statistics

Elastic NV vs Gilead Sciences, Inc. — how do they compare? Elastic NV trades at $75.22 (market cap $7.94B), while Gilead Sciences, Inc. trades at $135.34 (market cap $168.35B). The key difference: Gilead Sciences, Inc. is far larger — about 21.2× Elastic NV's market cap, and Gilead Sciences, Inc. pays a 2.42% dividend while Elastic NV pays none. Which is the better fit depends on your goals.

ESTCGILD
Market Cap
$7.94B$168.35B
Sector
TechnologyHealth
52-Week High
$94.47$155.80
52-Week Low
$43.30$110.56
Enterprise Value
$7.16B$191.42B
Dividend Yield
2.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Elastic NV

Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.

Read more on ESTC

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD